Results 71 to 80 of about 586,608 (155)

Omnipod 5 Delivers Superior Economic Value Compared to Multiple Daily Injections: A Cost‐Effectiveness Analysis in Adults With T1D From a Payer Perspective in Sweden

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10142-10152, November 2026.
ABSTRACT Aim Analyse the cost‐effectiveness of the Omnipod 5 automated insulin delivery system versus multiple daily injections (MDI) with continuous glucose monitoring for type 1 diabetes among adults in Sweden. Methods Cost‐effectiveness was analysed with the IQVIA Core Diabetes Model (version 10.0) taking the perspective of the payer in Sweden ...
Johan Jendle, Colin Hopley, Anuj Narang, Raffaele Scarica, Helena Hellerstedt, Melanie Littlewood   +5 more
wiley   +1 more source

Glucose values from the same continuous glucose monitoring sensor significantly differ among readers with different generations of algorithm

Scientific Reports
Continuous glucose monitoring (CGM) values obtained from CGM systems using the same sensor but with different internal algorithms (the first- and third-generation FreeStyle Libre (1st-gen-libre and 3rd-gen-libre, respectively)) were compared.
Naru Babaya, Shinsuke Noso, Yoshihisa Hiromine, Yasunori Taketomo, Fumimaru Niwano, Sawa Yoshida, Sara Yasutake, Yumiko Kawabata, Norikazu Maeda, Hiroshi Ikegami   +9 more
doaj   +1 more source

Person‐Reported and Continuous Glucose Monitoring (CGM) Recorded Hypoglycaemia in People With Insulin‐Treated Type 2 Diabetes and Mild to Moderate Chronic Kidney Disease; Post Hoc Analysis From the Hypo‐METRICS Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10664-10669, November 2026.
ABSTRACT Background and Aims People with diabetes and chronic kidney disease (CKD) may be at increased risk of iatrogenic hypoglycaemia. We compared rates of sensor‐detected (SDH) and person‐reported hypoglycaemia (PRH) in people with insulin‐treated Type 2 diabetes (T2D) with and without CKD in the Hypo‐METRICS study.
Julie M. B. Brøsen, Daniel Malmsiø, Patrick Divilly, Gilberte Martine‐Edith, Natalie Zaremba, Namam Ali, Rory J. McCrimmon, Simon Heller, Mark Evans, Bastiaan de Galan, Julia K. Mader, Eric Renard, Allan A. Vaag, Pratik Choudhary, Ulrik Pedersen‐Bjergaard, on behalf of the HypoRESOLVE Consortium, Andrew Pernet, Amy Aldridge, Marcia Henderson‐Wilson, Pernille Banck‐Petersen, Rikke Carstensen, Charlotte Hansen, Sharon Caunt, Sue Hudson, Chloe Husband, Fahad Arshad, Anne Farret, Anne‐Marie Marteil‐Oudrer, Manal Shbat, Lisa Crespy, Jenny Constanza Thibout, Anja Rasing, Jesper Walburgh Schimidt, Daniel Loewenstein, Renate Huijsmans, Pieter Drijver, Daniel Chapman, Jane Kennet, Anna Barnett, Jackie Lindsay   +39 more
wiley   +1 more source

FreeStyle Libre and Dexcom G4 Platinum sensors: Accuracy comparisons during two weeks of home use and use during experimentally induced glucose excursions

, 2018
This study compared the accuracy of the FreeStyle Libre (Abbott, Alameda, CA) and Dexcom G4 Platinum (DG4P, Dexcom, San Diego, CA) CGM ...
Marescotti, M C, Facchinetti, A, Bruttomesso, D, Vallone, V, Avogaro, A, A. Facchinetti, A. Avogaro, F. Boscari, M.C. Marescotti, A.M.L. Amato, Amato, A M L, Galasso, S, V. Vallone, D. Bruttomesso, S. Galasso, Boscari, F   +15 more
core   +1 more source

Rationale and design of a randomised phase II multicentre crossover trial investigating a sodium-glucose co-transporter 2 inhibitor, dapagliflozin, combined with a novel continuous ketone monitor in adults with type 1 diabetes to reduce the risk of diabetic ketoacidosis: the PARTNER study

BMJ Open
Introduction Sodium-glucose co-transporter inhibitors have potential glycaemic and non-glycaemic benefits in people with type 1 diabetes (T1D). However, the increased risk of diabetic ketoacidosis (DKA) limits their widespread use.
Yee Wen Kong, Sara Vogrin, Elif Ekinci, Pamela Taylor, David Norman O’Neal, Alicia Jenkins, Stephen N Stranks, Steven Trawley, Christopher J Nolan, Lynelle Boisseau, Jennifer Ngan, Jenna Goad, Michael L H Huang, Adele Manzoney, Miyuki Nakano, Adamandia Kriketos, Spiros Fourlanos, Joanne Fenn   +17 more
doaj   +1 more source

Internet of Things Based on Electronic and Mobile Health Systems for Blood Glucose Continuous Monitoring and Management

IEEE Access, 2019
Over 425 million people suffer from diabetes worldwide and this number is expected to increase over the years. Rigorous and extensive research has led to the development of increasingly advanced technologies, such as continuous glucose monitoring and ...
Jose Jorge Rodrigues Barata, Roberto Munoz, Rafael D. De Carvalho Silva, Joel J. P. C. Rodrigues, Victor Hugo C. De Albuquerque   +4 more
doaj   +1 more source

The Impact of Diabetes Education on Continuous Glucose Monitoring in SUS-Dependent Patients in a Northeastern Brazilian City

Life
Background: Diabetes Mellitus (DM) is an important chronic disease that occurs worldwide. Aims: This study aims to investigate how the use of the FreeStyle® Libre system in Unified Health System (SUS) patients impacts diabetes parameters in patients who ...
Lysandro Pinto Borges, Pamela Chaves de Jesus, Jessiane Bispo de Souza, Deise Maria Rego Rodrigues Silva, Pedro Henrique Macedo Moura, Ronaldy Santana Santos, Marina dos Santos Barreto, Adriana Gibara Guimarães, Lucas Alves da Mota Santana, Dennyson Leandro Mathias da Fonseca, Ikaro Daniel de Carvalho Barreto, Breno de Mello Silva, Carla Raquel Pereira Oliveira, Karla Freire Rezende, Naira Horta Melo, Elenalda Ferreira dos Santos, Carmem Lúcia Matias de Queiroz, Lucia Helena Modesto Xavier, Otávio Cabral-Marques, Eloia Emanuelly Dias Silva   +19 more
doaj   +1 more source

Effect of 6 months’ flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a ‘flash’ randomised controlled trial protocol

BMC Endocrine Disorders, 2019
Background Teenagers and young adults with type 1 diabetes (T1D) experience significant burden managing this serious chronic condition and glycaemic control is at its unhealthiest during this life stage. Flash glucose monitoring (FGM) is a new technology
Sara E. Boucher, Andrew R. Gray, Martin de Bock, Esko J. Wiltshire, Barbara C. Galland, Paul A. Tomlinson, Jenny Rayns, Karen E. MacKenzie, Benjamin J. Wheeler   +8 more
doaj   +1 more source

The impact of continuing glucose (FreeStyle Libre) monitoring on the diabetes regulation and life quality of the patients with diabetes

, 2021
Šećerna bolest je jedna od najčešćih kroničnih nezaraznih bolesti, a možemo je svrstati u globalne epidemije jer broj oboljelih svakodnevno raste. Obzirom da je šećerna bolest bolest kroničnog tipa, sa sobom nosi rizik razvoja kroničnih komplikacija na ...
Jozinović, Dijana
core   +1 more source

Beyond the CE Mark: A Call to Action for Minimum CGM Accuracy Standards in Central and Eastern European Nations

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 9747-9752, November 2026.
Tomasz Klupa, Silvija Canecki‐Varžić, Adriana Ilavská, Andrej Janez, Sanja Klobučar, Mladen Krnić, Tatjana Milenkovic, Peter Novodvorský, Martin Prázný, Marko Simunovic, Jan Šoupal, Anca Pantea Stoian, Agnieszka Szadkowska, Tsvetelina Tankova, Tadej Battelino   +14 more
wiley   +1 more source